TrialClinical and translational science2024

Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers.

Hengbang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.